Alembic Pharma rises on successful inspection at Bioequivalence facility
Alembic Pharma rises on successful inspection at Bioequivalence facility

Alembic Pharma rises on successful inspection at Bioequivalence facility

Amir Shaikh Article rating: 5.0

Gujarat-based pharmaceutical company Alembic Pharma informed the bourses on Wednesday that US Food & Drug Administration (USFDA) has successfully completed inspection at its Bioequivalence facility located at Vadodara.

Personal finance rules that one should follow
Personal finance rules that one should follow

Personal finance rules that one should follow

Henil Shah Article rating: 4.5

Whether it is your investment or your financial goals, there are certain personal finance rules that one should follow to get the most out of it. What are those rules? Let’s find out.

Risk Tolerance Revealed
Risk Tolerance Revealed

Risk Tolerance Revealed

Shashikant Singh Article rating: 5.0

Risk as a concept is not understood by many and they believe risks to be same as loss. Read on to find the difference between the two.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Anupama Pattanaik Article rating: 3.0

Overall volumes in futures & options currently stand at 1,64,89,491 contracts with a turnover of Rs. 10,69,260.44 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Anupama Pattanaik Article rating: 4.2

Overall volumes in futures & options currently stand at 1,64,89,491 contracts with a turnover of Rs. 10,69,260.44 crore.

Index trend and stocks in action August 21, 2019
Index trend and stocks in action August 21, 2019

Index trend and stocks in action August 21, 2019

Karan Dsij Article rating: 2.5

The zone of 10,935-10,990 is a major support zone. If Nifty manages to hold above this zone, a possibility of an intraday pullback cannot be ruled out. In this scenario, the level of 11,080 is likely to act as an immediate resistance followed by 11,145 levels. Stocks in news: KRBL, Alembic Pharmaceuticals, IOL Chemicals and Pharmaceuticals, Zensar Technologies, NMDC.

Lower opening awaits indices
Lower opening awaits indices

Lower opening awaits indices

Karan Dsij Article rating: 5.0

Going by early indication of SGX Nifty, the market is set to open on a negative note amidst sluggish global clues.

Rupee depreciated for second consecutive session
Rupee depreciated for second consecutive session

Rupee depreciated for second consecutive session

Nidhi Jani Article rating: 5.0

Indian rupee weakened for second consecutive session on Tuesday against the US dollar, due to rising crude oil prices along with stronger dollar.

RSS
First30763077307830793081308330843085Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR